EXHIBIT 99.1
JOINT FILING AGREEMENT
The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Common Stock of Skye Bioscience, Inc. shall be filed on behalf of each of the undersigned and that this Joint Filing Agreement shall be filed as an exhibit to such Schedule 13D.
Dated: December 19, 2024
5AM Ventures VII, L.P. By: 5AM Partners VII, LLC its General Partner By: /s/ Andrew J. Schwab
Name: Andrew J. Schwab Title: Managing Member | 5AM Partners VII, LLC By: /s/ Andrew J. Schwab
Name: Andrew J. Schwab Title: Managing Member |
5AM Ventures II, L.P. By: 5AM Partners II, LLC its General Partner By: /s/ Andrew J. Schwab
Name: Andrew J. Schwab Title: Managing Member 5AM Co-Investors II, L.P. By: 5AM Partners II, LLC its General Partner By: /s/ Andrew J. Schwab
Name: Andrew J. Schwab Title: Managing Member | 5AM Partners II, LLC By: /s/ Andrew J. Schwab
Name: Andrew J. Schwab Title: Managing Member |
/s/ Andrew J. Schwab
Andrew J. Schwab /s/ Dr. Kush Parmar Dr. Kush Parmar /s/ Dr. John D. Diekman Dr. John D. Diekman /s/ Dr. Scott M. Rocklage
Dr. Scott M. Rocklage |
